目标聚焦情绪调节疗法(GET)用于年轻睾丸癌生存者的试点随机对照试验方案
该试点随机对照试验将年轻成年睾丸癌生存者随机分配接受6次目标聚焦情绪调节疗法(GET)或个体支持疗法(ISP),在8周内完成。主要评估干预可行性和抑郁焦虑症状,次要评估情绪调节、目标导航技能和职业困惑,并在基线和12周后测量生物标志物。
要点
- GET为6次结构化干预,旨在改善心理困扰和情绪调节。
- 主要结局为抑郁和焦虑症状,次要结局包括目标导航技能。
- 同时评估应激敏感生物标志物,探索生物行为机制。
核心结论
- GET可能改善年轻睾丸癌生存者的自我调节和癌症适应,但尚需试验验证。
研究设计与样本
- 试点随机对照试验,将参与者随机分配接受6次GET或ISP,8周内完成。
- 评估时间点为干预前(T0)、干预后立即(T1)和干预后12周(T2)。
主要发现
- 原文未报告试验结果,仅描述研究方案。
关键数值与推荐
- 主要结局为抑郁和焦虑症状,次要结局为情绪调节、目标导航技能和职业困惑。
- 生物标志物在基线和T2测量。
- 干预为6次GET或ISP,8周内完成。
临床怎么用
- 若试验可行且初步有效,GET或可成为年轻睾丸癌生存者的靶向支持治疗。
局限性
- 为试点试验方案,样本量和可行性指标未在摘要中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young adulthood and the majority of young survivors experience impairing, distressing, and modifiable adverse outcomes that can persist long after medical treatment. These include psychological distress, impairment in pursuit of life goals, persistent physical side effects, elevated risk of secondary malignancies and chronic illness, and biobehavioral burden (e.g., enhanced inflammation, dysregulated diurnal stress hormones). However, few targeted interventions exist to assist young survivors in renegotiating life goals and regulating cancer-related emotions, and none focus on reducing the burden of morbidity via biobehavioral mechanisms. This paper describes the methodology of a randomized controlled biobehavioral trial designed to investigate the feasibility and preliminary impact of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET), aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. METHODS: Participants will be randomized to receive six sessions of GET or Individual Supportive Therapy (ISP) delivered over 8 weeks. In addition to indicators of intervention feasibility, we will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), and 12 weeks after (T2) intervention. Additionally, identified biomarkers will be measured at baseline and at T2. DISCUSSION: GET may have the potential to improve self-regulation across biobehavioral domains, improve overall cancer adjustment, and address the need for targeted supportive care interventions for young adult cancer survivors. TRIAL REGISTRATION: Clinicaltrials.gov, NCT04150848. Registered on 28 October 2019.
引用
- Hoyt MA, Wang AW, Ryan SJ, et al. Goal-Focused Emotion-Regulation Therapy (GET) for young adult survivors of testicular cancer: a pilot randomized controlled trial of a biobehavioral intervention protocol. Trials. 2020. PMID: 32290859. doi:10.1186/s13063-020-04242-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。